HEADER HYDROLASE/HYDROLASE INHIBITOR 31-AUG-01 1JVQ TITLE CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN, TITLE 2 A P14-P8 REACTIVE LOOP PEPTIDE, AND AN EXOGENOUS TETRAPEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTITHROMBIN-III; COMPND 3 CHAIN: L, I; COMPND 4 SYNONYM: ANTITHROMBIN, SERINE (OR CYSTEINE) PROTEINASE INHIBITOR, COMPND 5 CLADE C (ANTITHROMBIN), MEMBER 1; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: P14-P8 REACTIVE LOOP PEPTIDE; COMPND 8 CHAIN: C; COMPND 9 FRAGMENT: HUMAN ANTITHROMBIN P14-P8 PEPTIDE; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: EXOGENOUS CHOLECYSTOKININ TETRAPEPTIDE; COMPND 13 CHAIN: D; COMPND 14 FRAGMENT: CHOLECYSTOKININ PEPTIDE; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: BLOOD; SOURCE 6 OTHER_DETAILS: PLASMA; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HUMAN ANTITHROMBIN; SOURCE 10 MOL_ID: 3; SOURCE 11 SYNTHETIC: YES; SOURCE 12 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN CHOLECYSTOKININ KEYWDS LOOP-SHEET POLYMER, BETA-BARREL, BLOOD CLOTTING, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.ZHOU,J.A.HUNTINGTON,D.A.LOMAS,R.W.CARRELL,P.E.STEIN REVDAT 8 13-NOV-24 1JVQ 1 REMARK REVDAT 7 16-AUG-23 1JVQ 1 HETSYN REVDAT 6 29-JUL-20 1JVQ 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 13-JUL-11 1JVQ 1 VERSN REVDAT 4 24-FEB-09 1JVQ 1 VERSN REVDAT 3 18-APR-06 1JVQ 1 SHEET REVDAT 2 22-MAR-05 1JVQ 1 JRNL SHEET REMARK REVDAT 1 03-JUN-03 1JVQ 0 JRNL AUTH A.ZHOU,P.E.STEIN,J.A.HUNTINGTON,P.SIVASOTHY,D.A.LOMAS, JRNL AUTH 2 R.W.CARRELL JRNL TITL HOW SMALL PEPTIDES BLOCK AND REVERSE SERPIN POLYMERISATION JRNL REF J.MOL.BIOL. V. 342 931 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 15342247 JRNL DOI 10.1016/J.JMB.2004.07.078 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.63 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 34378 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1029 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5477 REMARK 3 BIN R VALUE (WORKING SET) : 0.3400 REMARK 3 BIN FREE R VALUE : 0.3740 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 173 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6622 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 135 REMARK 3 SOLVENT ATOMS : 44 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.85000 REMARK 3 B22 (A**2) : 7.68000 REMARK 3 B33 (A**2) : -8.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -6.07000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.41 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.42 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.54 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.940 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 47.63 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JVQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-SEP-01. REMARK 100 THE DEPOSITION ID IS D_1000014239. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.488 REMARK 200 MONOCHROMATOR : COOLED LIQUID GALLIUM REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, TRUNCATE REMARK 200 DATA SCALING SOFTWARE : CCP4 (TRUNCATE) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34380 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 40.550 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.700 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : 0.08800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.64800 REMARK 200 R SYM FOR SHELL (I) : 0.55700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: HUMAN ANTITHROMBIN BINARY COMPLEX, PDB ID 1BR8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, AMMONIUM FLUORIDE, PH 7.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP AT 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.31100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 35230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, I, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS L 1 REMARK 465 GLY L 2 REMARK 465 SER L 3 REMARK 465 PRO L 4 REMARK 465 ARG L 24 REMARK 465 SER L 25 REMARK 465 PRO L 26 REMARK 465 GLU L 27 REMARK 465 LYS L 28 REMARK 465 LYS L 29 REMARK 465 ALA L 30 REMARK 465 THR L 31 REMARK 465 GLU L 32 REMARK 465 ASP L 33 REMARK 465 GLU L 34 REMARK 465 GLY L 35 REMARK 465 SER L 36 REMARK 465 GLU L 37 REMARK 465 GLN L 38 REMARK 465 LYS L 39 REMARK 465 ILE L 40 REMARK 465 PRO L 41 REMARK 465 GLU L 42 REMARK 465 ALA L 43 REMARK 465 THR L 44 REMARK 465 LYS L 432 REMARK 465 HIS I 1 REMARK 465 GLY I 2 REMARK 465 SER I 3 REMARK 465 PRO I 4 REMARK 465 LYS I 28 REMARK 465 LYS I 29 REMARK 465 ALA I 30 REMARK 465 THR I 31 REMARK 465 GLU I 32 REMARK 465 ASP I 33 REMARK 465 GLU I 34 REMARK 465 GLY I 35 REMARK 465 SER I 36 REMARK 465 GLU I 37 REMARK 465 GLN I 38 REMARK 465 LYS I 39 REMARK 465 ILE I 40 REMARK 465 PRO I 41 REMARK 465 GLU I 381 REMARK 465 ALA I 382 REMARK 465 ALA I 383 REMARK 465 LYS I 432 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN L 155 O1 NDG L 841 2.14 REMARK 500 NZ LYS L 91 NE2 HIS L 120 2.15 REMARK 500 O4 NAG I 861 O1 NDG I 862 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA L 10 151.71 -49.63 REMARK 500 ASN L 18 43.38 -109.67 REMARK 500 ASP L 72 -12.07 -40.14 REMARK 500 ASN L 96 -131.94 56.02 REMARK 500 SER L 112 80.59 -69.17 REMARK 500 ASN L 135 -76.07 -50.53 REMARK 500 ASN L 178 56.30 -153.19 REMARK 500 ALA L 242 -70.44 -35.30 REMARK 500 ARG L 261 124.84 -175.08 REMARK 500 VAL L 263 -162.14 -110.79 REMARK 500 GLU L 265 16.68 58.94 REMARK 500 ASP L 277 -8.46 72.52 REMARK 500 PHE L 329 166.60 177.62 REMARK 500 ASP L 361 68.44 71.05 REMARK 500 ASP L 366 167.57 179.67 REMARK 500 PRO L 397 98.32 -31.91 REMARK 500 VAL L 400 75.40 -153.08 REMARK 500 PHE L 402 99.26 175.92 REMARK 500 ALA L 404 -123.48 -121.22 REMARK 500 ASN L 405 167.03 179.61 REMARK 500 ARG L 406 59.79 33.16 REMARK 500 ALA I 43 12.38 175.58 REMARK 500 ASN I 96 -125.01 49.19 REMARK 500 ILE I 111 69.64 -107.56 REMARK 500 SER I 112 126.32 -15.27 REMARK 500 GLU I 113 -8.64 58.37 REMARK 500 TYR I 131 43.17 -100.58 REMARK 500 ASN I 178 73.92 -108.83 REMARK 500 THR I 199 -105.30 -83.63 REMARK 500 ALA I 206 179.04 -53.83 REMARK 500 ILE I 207 109.88 64.93 REMARK 500 ASN I 208 -95.65 -128.50 REMARK 500 GLU I 209 -31.60 -143.44 REMARK 500 ARG I 261 131.60 -174.73 REMARK 500 VAL I 263 -157.51 -94.61 REMARK 500 ASP I 277 -13.32 68.72 REMARK 500 TRP I 307 -70.06 -40.89 REMARK 500 GLU I 357 95.83 76.04 REMARK 500 ARG I 359 32.90 70.74 REMARK 500 ASP I 361 4.64 166.88 REMARK 500 ASN I 376 -158.28 -172.28 REMARK 500 GLU I 378 -3.13 59.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BR8 RELATED DB: PDB REMARK 900 2.9A STRUCTURE OF BINARY COMPLEXED ANTITHROMBIN. THIS IS DIMERIC REMARK 900 ANTITHROMBIN COMPLEXED WITH A 12 RESIDUE PEPTIDE CORRESPONDING TO REMARK 900 P14-P3 OF THE REACTIVE CENTRE LOOP DBREF 1JVQ L 1 432 UNP P01008 ANT3_HUMAN 33 464 DBREF 1JVQ I 1 432 UNP P01008 ANT3_HUMAN 33 464 DBREF 1JVQ C 1 8 PDB 1JVQ 1JVQ 1 8 DBREF 1JVQ D 9 13 PDB 1JVQ 1JVQ 9 13 SEQRES 1 L 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 L 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 L 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 L 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 L 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 L 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 L 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 L 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 L 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 L 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 L 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 L 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 L 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 L 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 L 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 L 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 L 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 L 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 L 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 L 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 L 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 L 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 L 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 L 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 L 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 L 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 L 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 L 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 L 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 L 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 L 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 L 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 L 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 L 432 CYS VAL LYS SEQRES 1 I 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 I 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 I 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 I 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 I 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 I 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 I 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 I 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 I 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 I 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 I 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 I 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 I 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 I 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 I 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 I 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 I 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 I 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 I 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 I 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 I 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 I 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 I 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 I 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 I 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 I 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 I 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 I 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 I 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 I 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 I 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 I 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 I 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 I 432 CYS VAL LYS SEQRES 1 C 8 ACE SER GLU ALA ALA ALA SER THR SEQRES 1 D 5 TRP MET ASP PHE NH2 HET ACE C 1 3 HET NH2 D 13 1 HET NDG L 801 15 HET NDG L 841 15 HET NDG L 842 15 HET NDG L 861 15 HET NDG I 801 15 HET NAG I 841 15 HET NDG I 842 15 HET NAG I 861 15 HET NDG I 862 15 HETNAM ACE ACETYL GROUP HETNAM NH2 AMINO GROUP HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 ACE C2 H4 O FORMUL 4 NH2 H2 N FORMUL 5 NDG 7(C8 H15 N O6) FORMUL 10 NAG 2(C8 H15 N O6) FORMUL 14 HOH *44(H2 O) HELIX 1 1 ASN L 45 ASP L 68 1 24 HELIX 2 2 SER L 79 LEU L 92 1 14 HELIX 3 3 CYS L 95 PHE L 106 1 12 HELIX 4 4 LYS L 107 ILE L 111 5 5 HELIX 5 5 THR L 115 ARG L 132 1 18 HELIX 6 6 ASN L 155 TYR L 166 1 12 HELIX 7 7 ASP L 174 THR L 194 1 21 HELIX 8 8 PRO L 203 ILE L 207 5 5 HELIX 9 9 ALA L 264 GLY L 266 5 3 HELIX 10 10 SER L 291 LYS L 297 1 7 HELIX 11 11 THR L 300 LEU L 311 1 12 HELIX 12 12 LEU L 331 MET L 338 1 8 HELIX 13 13 VAL L 341 SER L 345 5 5 HELIX 14 14 LYS I 11 ILE I 15 5 5 HELIX 15 15 ASN I 45 SER I 69 1 25 HELIX 16 16 SER I 79 LEU I 92 1 14 HELIX 17 17 CYS I 95 PHE I 106 1 12 HELIX 18 18 LYS I 107 ILE I 111 5 5 HELIX 19 19 THR I 115 TYR I 131 1 17 HELIX 20 20 ASN I 155 GLY I 167 1 13 HELIX 21 21 ASN I 178 THR I 194 1 17 HELIX 22 22 SER I 230 THR I 234 5 5 HELIX 23 23 ALA I 264 GLY I 266 5 3 HELIX 24 24 SER I 291 LEU I 299 1 9 HELIX 25 25 THR I 300 GLU I 310 1 11 HELIX 26 26 LEU I 331 MET I 338 1 8 HELIX 27 27 VAL I 341 SER I 345 5 5 SHEET 1 A 8 ILE L 76 LEU L 78 0 SHEET 2 A 8 THR L 419 VAL L 426 -1 O ARG L 425 N ILE L 76 SHEET 3 A 8 PHE L 408 GLU L 414 -1 N ILE L 412 O PHE L 422 SHEET 4 A 8 ILE L 279 LEU L 285 -1 N THR L 280 O ARG L 413 SHEET 5 A 8 GLN L 268 PRO L 273 -1 N LEU L 272 O MET L 281 SHEET 6 A 8 SER L 250 ARG L 262 -1 N ARG L 259 O GLU L 271 SHEET 7 A 8 GLU L 312 SER L 330 -1 O VAL L 318 N GLN L 254 SHEET 8 A 8 ARG L 235 LYS L 236 0 SHEET 1 B 8 LYS L 169 LEU L 173 0 SHEET 2 B 8 LYS L 139 ASP L 149 1 N LEU L 146 O GLN L 171 SHEET 3 B 8 LEU L 213 LEU L 224 -1 O TYR L 220 N VAL L 141 SHEET 4 B 8 GLY L 379 ILE L 390 -1 O ILE L 390 N LEU L 213 SHEET 5 B 8 VAL L 364 VAL L 375 -1 N GLU L 374 O GLU L 381 SHEET 6 B 8 GLU L 312 SER L 330 -1 N PHE L 323 O VAL L 375 SHEET 7 B 8 SER L 250 ARG L 262 -1 N GLN L 254 O VAL L 318 SHEET 8 B 8 THR I 386 ILE I 390 0 SHEET 1 C 2 THR L 153 PHE L 154 0 SHEET 2 C 2 VAL L 355 GLU L 357 -1 O GLU L 357 N THR L 153 SHEET 1 D 2 PHE L 239 TYR L 240 0 SHEET 2 D 2 SER L 246 CYS L 247 -1 O CYS L 247 N PHE L 239 SHEET 1 E 7 ILE I 76 LEU I 78 0 SHEET 2 E 7 THR I 419 VAL I 426 -1 O MET I 423 N LEU I 78 SHEET 3 E 7 PHE I 408 GLU I 414 -1 N PHE I 408 O VAL I 426 SHEET 4 E 7 ILE I 279 LEU I 285 -1 N THR I 280 O ARG I 413 SHEET 5 E 7 GLN I 268 PRO I 273 -1 N LEU I 272 O MET I 281 SHEET 6 E 7 SER I 246 ARG I 262 -1 N ARG I 259 O GLU I 271 SHEET 7 E 7 ARG I 235 TYR I 240 -1 N GLU I 237 O ALA I 249 SHEET 1 F 8 ILE I 76 LEU I 78 0 SHEET 2 F 8 THR I 419 VAL I 426 -1 O MET I 423 N LEU I 78 SHEET 3 F 8 PHE I 408 GLU I 414 -1 N PHE I 408 O VAL I 426 SHEET 4 F 8 ILE I 279 LEU I 285 -1 N THR I 280 O ARG I 413 SHEET 5 F 8 GLN I 268 PRO I 273 -1 N LEU I 272 O MET I 281 SHEET 6 F 8 SER I 246 ARG I 262 -1 N ARG I 259 O GLU I 271 SHEET 7 F 8 GLU I 312 PRO I 321 -1 O VAL I 318 N GLN I 254 SHEET 8 F 8 VAL I 400 LYS I 403 1 O PHE I 402 N HIS I 319 SHEET 1 G 6 LYS I 169 LEU I 173 0 SHEET 2 G 6 LYS I 139 ASP I 149 1 N LEU I 146 O LYS I 169 SHEET 3 G 6 LEU I 213 GLY I 223 -1 O TYR I 220 N VAL I 141 SHEET 4 G 6 SER C 2 ALA C 4 -1 O ALA C 4 N PHE I 221 SHEET 5 G 6 ASP I 366 VAL I 375 -1 N PHE I 368 O TRP D 9 SHEET 6 G 6 PHE I 323 SER I 330 -1 N ASP I 327 O ALA I 371 SSBOND 1 CYS L 8 CYS L 128 1555 1555 2.03 SSBOND 2 CYS L 21 CYS L 95 1555 1555 2.03 SSBOND 3 CYS L 247 CYS L 430 1555 1555 2.03 SSBOND 4 CYS I 8 CYS I 128 1555 1555 2.05 SSBOND 5 CYS I 21 CYS I 95 1555 1555 2.03 SSBOND 6 CYS I 247 CYS I 430 1555 1555 2.03 LINK C ACE C 1 N SER C 2 1555 1555 1.33 LINK C PHE D 12 N NH2 D 13 1555 1555 1.24 CRYST1 69.144 100.622 87.157 90.00 104.42 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014463 0.000000 0.003719 0.00000 SCALE2 0.000000 0.009938 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011847 0.00000